Jun 02, 2022
SALT LAKE CITY, June 2, 2022 / PRNewswire / --  Recursion  (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conferences: Jefferies Healthcare Conference  — June 8 through
May 02, 2022
SALT LAKE CITY, May 2, 2022 / PRNewswire / --  Recursion  (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conference: Bank of America 2022 Healthcare Conference —  May
Mar 31, 2022
SALT LAKE CITY, March 31, 2022 / PRNewswire / --  Recursion  (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its participation in the following upcoming investor conferences: Piper Sandler AI/Machine Learning Conference — 
Mar 24, 2022
Releases inaugural report less than one year after becoming a publicly-traded company, demonstrating its strong commitment to ESG stewardship Announces new long-term commitments focused on net-zero greenhouse gas emissions, workforce diversity and philanthropy SALT LAKE CITY, March 24, 2022 /
Displaying 61 - 70 of 109